Arbutus Biopharma Corp (ABUS) — Defensive Interval Ratio
Arbutus Biopharma Corp (ABUS) has a Defensive Interval Ratio of 5207 days as of March 2026. Defensive assets of $72.83 Million (cash $-, short-term investments $71.52 Million, receivables $1.31 Million) cover 5207 days of daily cash needs of $13.99K/day. See Arbutus Biopharma Corp current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Arbutus Biopharma Corp Defensive Interval Ratio (1998–2025)
This chart shows how Arbutus Biopharma Corp's Defensive Interval Ratio has evolved across 28 annual periods from 1998 to 2025. As of March 2026, the ratio stands at 5207 days, meaning defensive assets of $72.83 Million can fund 5207 days of operations without new revenue. See debt-free asset ratio of Arbutus Biopharma Corp to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Arbutus Biopharma Corp (1998–2025)
The table below presents the year-by-year Defensive Interval Ratio for Arbutus Biopharma Corp from 1998 to 2025, covering 28 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Arbutus Biopharma Corp.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 4571 days | $75.21 Million | $16.45K/day | $- | $73.46 Million | ▲ +2498 days |
| 2024 | 2073 days | $88.70 Million | $42.79K/day | $- | $86.29 Million | ▲ +426 days |
| 2023 | 1647 days | $101.49 Million | $61.61K/day | $- | $99.72 Million | ▲ +342 days |
| 2022 | 1305 days | $117.49 Million | $90.02K/day | $- | $116.14 Million | ▼ -222 days |
| 2021 | 1527 days | $46.93 Million | $30.74K/day | $- | $46.03 Million | ▼ -1240 days |
| 2020 | 2767 days | $72.33 Million | $26.14K/day | $- | $71.02 Million | ▼ -42 days |
| 2019 | 2809 days | $60.24 Million | $21.45K/day | $- | $59.03 Million | ▼ -85 days |
| 2018 | 2894 days | $89.11 Million | $30.79K/day | $- | $87.67 Million | ▲ +670 days |
| 2017 | 2224 days | $72.50 Million | $32.60K/day | $- | $72.10 Million | ▼ -1474 days |
| 2016 | 3698 days | $107.40 Million | $29.04K/day | $- | $107.10 Million | ▲ +3149 days |
| 2015 | 549 days | $15.91 Million | $28.98K/day | $- | $14.53 Million | ▼ -529 days |
| 2014 | 1078 days | $42.53 Million | $39.45K/day | $- | $40.00 Million | ▲ +1068 days |
| 2013 | 10 days | $329.00K | $34.31K/day | $- | $0.00 | ▼ -106 days |
| 2012 | 115 days | $3.46 Million | $30.01K/day | $- | $0.00 | ▲ +52 days |
| 2011 | 63 days | $1.19 Million | $18.74K/day | $- | $0.00 | ▼ -105 days |
| 2010 | 168 days | $3.75 Million | $22.28K/day | $- | $0.00 | ▲ +97 days |
| 2009 | 71 days | $1.27 Million | $17.83K/day | $- | $0.00 | ▼ -428 days |
| 2008 | 500 days | $5.55 Million | $11.10K/day | $- | $4.71 Million | ▲ +396 days |
| 2007 | 104 days | $1.84 Million | $17.71K/day | $- | $0.00 | ▲ +66 days |
| 2006 | 38 days | $604.55K | $15.93K/day | $- | $0.00 | ▼ -5 days |
| 2005 | 43 days | $259.96K | $6.05K/day | $- | $0.00 | ▼ -17 days |
| 2004 | 60 days | $1.80 Million | $29.82K/day | $- | $0.00 | ▼ -265 days |
| 2003 | 325 days | $4.04 Million | $12.42K/day | $- | $3.65 Million | ▼ -1058 days |
| 2002 | 1383 days | $18.19 Million | $13.15K/day | $- | $17.67 Million | ▼ -1997 days |
| 2001 | 3380 days | $23.92 Million | $7.08K/day | $- | $21.93 Million | ▼ -974 days |
| 2000 | 4354 days | $22.73 Million | $5.22K/day | $- | $21.93 Million | ▲ +1806 days |
| 1999 | 2548 days | $9.24 Million | $3.63K/day | $- | $8.71 Million | ▼ -33 days |
| 1998 | 2581 days | $5.87 Million | $2.28K/day | $- | $5.66 Million | — |